Beta-2-glycoprotein I and urinary trypsin inhibitor levels in the plasma of pregnant and postpartum women

Thrombosis Research

Volumn 117, Issue 3, 2006, Pages 255-261

  Masuda, Junko ^a   Suzuki, Kimihiro ^b   Satoh, Ayano ^a   Kojima Aikawa, Kyoko ^a   Nakanishi, Kuniaki ^b   Kuroda, Koichi ^b   Murakami, Mitsutaka ^c   Takayama, Eiji ^b   Matsumoto, Isamu ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Japan Self Defense Force Sendai Hospital   (Japan)

Author keywords

2 glycoprotein I; Annexin; Disseminated intravascular coagulation; Pregnancy; Thrombosis; Urinary trypsin inhibitor (Bikunin)

Indexed keywords

BETA2 GLYCOPROTEIN 1; D DIMER; LIPOCORTIN 4; LIPOCORTIN 5; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; ULINASTATIN;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; MATERNAL PLASMA; NORMAL HUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY;

ANNEXIN A5; ANNEXINS; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MODELS, STATISTICAL; PLACENTA; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, THIRD; REFERENCE VALUES; TIME FACTORS;

EID: 29244438988     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.026     Document Type: Article

References (32)

1. K. Kojima, H.K. Ogawa, N. Seno, and I. Matsumoto Affinity purification and affinity characterization of carbohydrate-binding proteins in bovine kidney J Chromatogr 597 1992 323 330
2. K. Kojima, K. Yamamoto, T. Irimura, T. Osawa, H. Ogawa, and I. Matsumoto Characterization of carbohydrate-binding protein p33/41: relation with annexin IV, molecular basis of the doublet forms (p33 and p41), and modulation of the carbohydrate binding activity by phospholipids J Biol Chem 271 1996 7679 7685
3. K. Kojima, H. Utsumi, H. Ogawa, and I. Matsumoto Highly polarized expression of carbohydrate-binding protein p33/41 (annexin IV) on the apical plasma membrane of epithelial cells in renal proximal tubules FEBS Lett 342 1994 313 318
4. R. Ishitsuka, K. Kojima, H. Utsumi, H. Ogawa, and I. Matsumoto Glycosaminoglycan binding properties of annexin IV, V, and VI J Biol Chem 273 1998 9935 9941
5. Y. Tsujii-Hayashi, M. Kitahara, T. Yamagaki, K. Kojima-Aikawa, and I. Matsumoto A potential endogenous ligand of annexin IV in the exocrine pancreas. Carbohydrate structure of GP-2, a glycosylphosphatidylinositol-anchored glycoprotein of zymogen granule membranes J Biol Chem 277 2002 47493 47499
6. E.A. Letsky Disseminated intravascular coagulation Best Pract Res Clin Obstet Gynaecol 4 2001 623 644
7. J. Masuda, E. Takayama, A. Satoh, M. Ida, T. Shinohara, and K. Kojima-Aikawa Levels of annexin IV and V in the plasma of pregnant and postpartum women Thromb Haemost 91 2004 1129 1136
8. H.H. Wang, and A.N. Chiang Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity Biochem J 380 2004 455 463
9. M. Averna, G. Paravizzini, G. Marino, G. Emmanuele, A.B. Cefalu, and G. Magro Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes Int J Biochem Cell Biol 36 2004 1297 1305
10. A. Satoh, K. Suzuki, E. Takayama, K. Kojima, T. Hidaka, and M. Kawakami Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus J Rheumatol 26 1999 1715 1720
11. M. Suzuki, H. Kobayashi, Y. Tanaka, N. Kanayama, and T. Terao Reproductive failure in mice lacking inter-alpha-trypsin inhibitor (ITI)-ITI target genes in mouse ovary identified by microarray analysis J Endocrinol 183 2004 29 38
12. L. Zhuo, A. Salustri, and K. Kimata A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role Glycoconj J 19 2002 241 247
13. H. Sato, S. Kajikawa, S. Kuroda, Y. Horisawa, N. Nakamura, and N. Kaga Impaired fertility in female mice lacking urinary trypsin inhibitor Biochem Biophys Res Commun 281 2001 1154 1160
14. E. El Maradny, N. Kanayama, A. Halim, K. Maehara, T. Kobayashi, and T. Terao Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries Gynecol Obstet Invest 41 1996 96 102
15. S. Donohoe, J.C. Kingdom, I.J. Mackie, S. Burrell, S. Quenby, and E. Jauniaux Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies Thromb Haemost 84 2000 32 38
16. B. Brenner Haemostatic changes in pregnancy Thromb Res 114 2004 409 414
17. J. Arvieux, B. Roussel, P. Pouzol, and M.G. Colomb Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I Thromb Haemost 70 1993 336 341
18. J. Nimpf, H. Wurm, and G.M. Kostner Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation Thromb Haemost 54 1985 397 401
19. J. Nimpf, H. Wurm, and G.M. Kostner Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation Atherosclerosis 63 1987 109 114
20. I. Schousboe, and M.S. Rasmussen The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation Int J Biochem 20 1988 787 792
21. S. Yasuda, T. Atsumi, M. Ieko, and T. Koike Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis Thromb Res 114 2004 461 465
22. 2+ in HL60 cells and HUVEC cells Biochem Biophys Res Commun 238 1997 560 564
23. S. Kajikawa, N. Kaga, Y. Futamura, and Y. Shibutani Tocolytic effect of magnesium sulfate and/or urinary trypsin inhibitor against lipopolysaccharide- induced preterm delivery in mice Acta Obstet Gynecol Scand 77 1998 598 602
24. P.F. Austin, A.J. Casale, M.P. Cain, R.C. Rink, and S.J. Weintraub Lipopolysaccharide and inflammatory cytokines cause an inducible nitric oxide synthase-dependent bladder smooth muscle fibrotic response J Urol 170 2003 645 648
25. H. Kobayashi, Y. Hirashima, and T. Terao Human myometrial cells in culture express specific binding sites for urinary trypsin inhibitor Mol Hum Reprod 6 2000 735 742
26. K. Takeuchi, A. Fukuda, and N. Kanayama Effect of urinary trypsin inhibitor on potassium currents: fetus modulates membrane excitability by production of UTI Acta Obstet Gynecol Scand 83 2004 6 11
27. N. Kanayama, E. El Maradny, N. Yamamoto, N. Tokunaga, K. Maehara, and T. Terao Urinary trypsin inhibitor: a new drug to treat preterm labor: a comparative study with ritodrine Eur J Obstet Gynecol Reprod Biol 67 1996 133 138
28. S.D. Lin, R. Endo, A. Sato, Y. Takikawa, K. Shirakawa, and K. Suzuki Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis J Gastroenterol Hepatol 17 2002 140 147
29. H. Morishita, T. Yamakawa, T. Matsusue, T Kusuyama, R. Sameshima-Aruga, and J. Hirose Novel factor Xa and plasma kallikrein inhibitory-activities of the second Kunitz-type inhibitory domain of urinary trypsin inhibitor Thromb Res 73 1994 193 204
30. M. Andrew, L. Mitchell, L. Berry, B. Paes, M. Delorme, and F. Ofosu An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus J Clin Invest 89 1992 321 326
31. S. Aosasa, S. Ono, H. Mochizuki, H. Tsujimoto, C. Ueno, and A. Matsumoto Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes Shock 15 2001 101 105
32. S. Aosasa, S. Ono, S. Seki, E. Takayama, T. Tadakuma, and H. Hiraide Inhibitory effect of protease inhibitor on endothelial cell activation J Surg Res 80 1998 182 187